iron deficiency anemia
Conditions
Interventions
None listed
Sponsors
Milliman Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with iron-deficiency anemia who have received IV iron treatment (1000 patients): Patients who have received IV iron treatment for iron-deficiency anemia in the past. 2. Patients with iron-deficiency anemia other than those in 1 (1000 patients): Patients who have been diagnosed as iron-deficiency anemia by doctors. 3. General population (20-69 years old, 1000 people): General people who are not included in 1 or 2. Note: iron-deficiency anemia patients will be included at the same rate as that of anemia patients in Japan. They will be collected according to the proportion of Japanese population by age group.
Exclusion criteria
Exclusion criteria: Patients/people who stop responding to the survey (not considered as respondents).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preference for factors about intravenous (IV) iron infusion: waiting time before receiving IV infusion, pain due to IV infusion, time required for the IV infusion (excluding follow-up time after the treatment), number of IV infusions required to achieve treatment effect, frequency of hypophosphatemia as a side effect after the IV infusion, frequency of deposition of the drug solution on the skin, and out-of-pocket cost for 1 IV infusion | — |
Countries
Japan
Contacts
Public ContactMidori Tateyama
Milliman Inc. Japan Healthcare Practice & Data Analytics
Outcome results
None listed